CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE

CORTISOL SUPPRESSION by DEXAMETHASONE, OVERNIGHT LOW DOSE is a specialized diagnostic endocrine test designed to screen for Cushing's syndrome and evaluate abnormal cortisol regulation. The test involves taking a low dose of dexamethasone (typically 1 mg) orally late at night, followed by measuring serum cortisol levels the following morning. In healthy individuals, exogenous dexamethasone suppresses the pituitary gland's release of ACTH, leading to a marked decrease in morning cortisol production. Failure of cortisol to suppress indicates autonomous cortisol hypersecretion, pointing toward Cushing's syndrome or other adrenal disorders.

Measurement of morning serum cortisol levels following overnight low-dose dexamethasone suppression provides direct clinical insight into hypothalamic-pituitary-adrenal (HPA) axis feedback integrity. Because early detection of hypercortisolism is critical for managing metabolic and cardiovascular complications, specialized suppression testing supplies essential clinical data for endocrinology and internal medicine.

The test requires a precise medication protocol followed by a simple venous blood sample collected by a qualified phlebotomist, analyzed using advanced immunoassay or chromatographic techniques. Results must always be interpreted in conjunction with the patient's clinical history, physical examination, and confirmatory endocrine evaluations.

Benefits of CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE Testing

• Provides a sensitive screening tool for detecting Cushing's syndrome and cortisol overproduction.
• Helps evaluate hypothalamic-pituitary-adrenal (HPA) axis feedback suppression.
• Assists clinicians in investigating unexplained obesity, hypertension, and glucose intolerance linked to hypercortisolism.
• Aids in guiding further confirmatory endocrine testing and specialist referrals.
• Supports tracking of complex endocrine disease investigations.
• Complements 24-hour urinary free cortisol assays, midnight salivary cortisol tests, and comprehensive adrenal profiles.
• Utilizes precise laboratory measurement techniques for reliable results.
• Assists specialists in determining appropriate endocrinological management strategies.
• Provides dependable turnaround times to support specialized clinical care.
• Utilizes a standard venous blood collection procedure following an overnight protocol.

Clinical Indications and Applications

Cushing's Syndrome Screening: The primary clinical indication is screening patients presenting with clinical signs suggestive of excess cortisol, such as central weight gain, facial rounding, easy bruising, and proximal muscle weakness.

Adrenal Feedback Assessment: The test is utilized when investigating suspected autonomous cortisol production or HPA axis dysfunction.

Why Doctors Recommend This Test

Endocrinologists and specialists recommend this overnight suppression test when screening for Cushing's syndrome or evaluating abnormal cortisol dynamics. It delivers essential diagnostic data required to guide safe clinical management.

Preparation Before the Test

Patients must strictly follow the precise dosing instructions provided by their doctor regarding the administration of the 1 mg dexamethasone tablet late at night (typically between 11:00 PM and midnight). Inform the healthcare team about all current medications, interfering drugs (such as anticonvulsants, estrogen-containing medications, or oral contraceptives), and relevant medical history.

Wearing comfortable clothing with sleeves that can be easily rolled up will facilitate a smooth and efficient blood collection process.

What Happens During the Procedure?

The procedure requires the patient to take a prescribed 1 mg dose of dexamethasone at night. The following morning (usually between 8:00 AM and 9:00 AM), the patient visits the laboratory for a standard venous blood draw (venipuncture) performed by a skilled phlebotomist to measure post-suppression serum cortisol levels.

The collected blood sample is promptly transported to the laboratory for specialized quantitative analysis. The entire blood collection process takes only a few minutes.

Normal Reporting Time

The report for the CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE test is generally available within 24 to 48 hours due to standard laboratory processing times. Results must be reviewed promptly with the referring endocrinologist or specialist.

Who Should Consider This Test?

• Patients presenting with physical signs and symptoms suggestive of Cushing's syndrome.
• Individuals evaluated for refractory hypertension, sudden weight gain, or poorly controlled diabetes linked to cortisol excess.
• Patients investigated for adrenal feedback abnormalities as directed by an endocrinologist.

Understanding Test Results

Test results provide the quantitative serum cortisol concentration following low-dose dexamethasone administration, evaluated against established endocrine reference thresholds.

Suppressed Findings: Cortisol levels dropping below the established cutoff threshold (typically < 1.8 ug/dL) indicate normal HPA axis feedback suppression, ruling out Cushing's syndrome.

Non-Suppressed Findings: Cortisol levels remaining above the cutoff threshold suggest autonomous cortisol hypersecretion, prompting further specialized endocrinological workup and confirmatory testing.

Clinical Limitations

Estrogen therapy, pregnancy, severe physiological or emotional stress, depression, and certain drugs altering liver metabolism can cause false-positive non-suppression results, requiring careful clinical correlation.

Important Safety Information

Severe blood pressure spikes, acute weakness, mental status changes, or crisis symptoms require immediate medical attention. Patients must consult their healthcare provider or endocrinologist to interpret suppression test findings.